News by Tag: Online Training - Page 2
MentorHealth to present webinar on "Issues with Consent Documents"
February 13, 2013
Summary: MentorHealth, a leading provider of online training for the healthcare industry, is organizing a webinar on March 27 on the topic, "Issues with Consent Documents".
February 13, 2013
Summary: MentorHealth, a leading provider of online training for the healthcare industry, is organizing a webinar on March 27 on the topic, "Issues with Consent Documents".
Webinar on
February 13, 2013
Summary: MentorHealth, a leading provider of online training for the healthcare industry, is organizing a webinar on the topic, "New HIPAA Rules - Meeting Requirements for New Patient Rights and New Restrictions on Disclosures" on March 21, 2013.
February 13, 2013
Summary: MentorHealth, a leading provider of online training for the healthcare industry, is organizing a webinar on the topic, "New HIPAA Rules - Meeting Requirements for New Patient Rights and New Restrictions on Disclosures" on March 21, 2013.
MentorHealth to present webinar on
February 13, 2013
Summary: "Hazard Meterials and Risk Assessment" is the topic of a webinar that MentorHealth, a leading provider of online training for the healthcare industry, is organizing on March 19.
February 13, 2013
Summary: "Hazard Meterials and Risk Assessment" is the topic of a webinar that MentorHealth, a leading provider of online training for the healthcare industry, is organizing on March 19.
Azuma Learning Introduces Cutting-Edge Online Software Training Programs for Academic and Corporate Organizations
February 5, 2013
Today, each organization wants to stay competitive.
February 5, 2013
Today, each organization wants to stay competitive.
OSHA's Hazard Communication Gets a New Look
December 20, 2012
This webinar will review the existing hazard communication standard and compare it to the changes that are found in the new standard.
December 20, 2012
This webinar will review the existing hazard communication standard and compare it to the changes that are found in the new standard.
Why is Drug Induced Liver Injury an Important Mirror of Drug Safety and How to Spot this early
December 20, 2012
Ferreting out which Investigational Medicinal Products (IMP) might cause significant liver injury is not an easy process partly.
December 20, 2012
Ferreting out which Investigational Medicinal Products (IMP) might cause significant liver injury is not an easy process partly.
Key concepts of OSHA Injury and Illness Recordkeeping - Webinar By MentorHealth
December 20, 2012
This webinar will explain the details of how to report and what to report on the OSHA Injury and Illness report.
December 20, 2012
This webinar will explain the details of how to report and what to report on the OSHA Injury and Illness report.
"Know Your Customer" - The DEA Due Diligence - Webinar By MentorHealth
December 20, 2012
This training will cover several recommendations to improve Due Diligence when distributing Schedules II through V controlled substances and regulated chemicals to your customers and what steps can be taken to prevent the illicit use.
December 20, 2012
This training will cover several recommendations to improve Due Diligence when distributing Schedules II through V controlled substances and regulated chemicals to your customers and what steps can be taken to prevent the illicit use.
How to Survive a DEA Audit - Webinar By MentorHealth
December 20, 2012
This training entitled "How to Survive a DEA Audit" will cover all the record-keeping and security requirements that a DEA registrant must comply with when handling controlled substances and regulated chemicals.
December 20, 2012
This training entitled "How to Survive a DEA Audit" will cover all the record-keeping and security requirements that a DEA registrant must comply with when handling controlled substances and regulated chemicals.
Assessing Risk in Human Research Protocols - Webinar By MentorHealth
December 20, 2012
45 CFR 46.111 (a)(2) states, "In evaluating risks and benefits, the IRB should consider only those risks and benefits that may result from the research (as distinguished from risks and benefits of therapies.
December 20, 2012
45 CFR 46.111 (a)(2) states, "In evaluating risks and benefits, the IRB should consider only those risks and benefits that may result from the research (as distinguished from risks and benefits of therapies.